Skip to main content
. 2024 Feb 21;12(2):e008518. doi: 10.1136/jitc-2023-008518

Figure 4.

Figure 4

Fatality rates of adverse events reported with bispecific T-cell engagers. The black dashed line denotes the average fatality rate of adverse events reported with bispecific T-cell engagers.

HHS Vulnerability Disclosure